Zur Hauptnavigation wechseln
Zur Suche wechseln
Zum Hauptinhalt wechseln
Technische Universität München Home
Hilfe und FAQ
English
Deutsch
Home
Personen
Einrichtungen
Projekte
Publikationen
Ausstattungen/Einrichtungen
Auszeichnungen
Aktivitäten
Presseberichte
Nach Expertise, Namen oder Zugehörigkeit suchen
Myc suppression of Nfkb2 accelerates lymphomagenesis
Ulrich Keller
, Jürgen Huber
, Jonas A. Nilsson
, Mohammad Fallahi
, Mark A. Hall
,
Christian Peschel
, John L. Cleveland
Default
Technische Universität München
St. Jude Children's Research Hospital
Umeå University
Department of Neuroscience
Publikation
:
Beitrag in Fachzeitschrift
›
Artikel
›
Begutachtung
27
Zitate (Scopus)
Übersicht
Fingerprint
Fingerprint
Untersuchen Sie die Forschungsthemen von „Myc suppression of Nfkb2 accelerates lymphomagenesis“. Zusammen bilden sie einen einzigartigen Fingerprint.
sortieren
Gewicht:
Alphabetisch
Immunology and Microbiology
B Cell
100%
Carboxy Terminal Sequence
50%
Cell Survival
50%
Cell Transformation
50%
Chromosome Translocation
50%
Fibroblast
50%
Immune Response
50%
In Vitro
50%
Lymphocyte Proliferation
50%
Mouse Model
50%
Oncogene C Myc
100%
Programmed Cell Death
50%
Promoter Region
50%
Transcription Factors
50%
Transgenic Mouse
100%
Transgenics
50%
Medicine and Dentistry
Ankyrin
33%
B Cell
66%
Burkitt's Lymphoma
100%
Cancer
33%
Carboxy Terminal Sequence
33%
Cell Survival
33%
Cell Transformation
33%
Chromosome Deletion
33%
Chromosome Translocation
33%
Fibroblast
33%
Immune Response
33%
In Vitro
33%
Lymphocyte Proliferation
33%
Malignant Neoplasm
33%
Oncogene C Myc
66%
Oncoprotein
33%
Programmed Cell Death
33%
Promoter Region
33%
Transcription Factors
33%
Transgenic Mouse
66%
Tumor
33%
Keyphrases
Aggressive Phenotype
10%
Ankyrin Repeat
10%
Apoptosis
10%
Apoptotic Response
10%
B Cells
20%
Burkitt Lymphoma
30%
C-Myc
10%
Cell Survival
10%
Cell Transformation
10%
Chromosomal Deletion
10%
Chromosomal Translocation
10%
Family Members
10%
Human Cancer
10%
Immune Cells
10%
In Cancer
10%
Lymphocyte Proliferation
10%
Lymphoid Malignancies
10%
Lymphoma
10%
Lymphomagenesis
100%
Mouse Embryonic Fibroblasts
10%
MYC Expression
10%
NF-B
30%
NFKB2
100%
Non-canonical
10%
Oncoprotein
10%
Overexpression
10%
Precancerous
10%
Reducing Activity
10%
Reporter Assay
10%
Transcription Factor
10%
Transgenic
10%
Transgenic Mice
10%
Transgenic Mouse Model
10%
Biochemistry, Genetics and Molecular Biology
Ankyrin
7%
B Cell
14%
C-Terminus
7%
Cell Survival
7%
Cell Transformation
7%
Chromosomal Translocation
7%
Fibroblast
7%
Immune Response
7%
Lymphocyte Proliferation
7%
Mouse Model
7%
Myc
100%
NFKB2
14%
Oncogene C Myc
14%
Programmed Cell Death
7%
Promoter Region
7%
Transcription
7%
Transcription Factors
7%
Transgenic Mouse
14%
Transgenics
7%